BIAWX
Price
$47.18
Change
-$0.24 (-0.51%)
Updated
Jul 13 closing price
Net Assets
4.35B
CGFAX
Price
$84.53
Change
-$1.36 (-1.58%)
Updated
Jul 13 closing price
Net Assets
356.86B
Interact to see
Advertisement

BIAWX vs CGFAX

BIAWX vs CGFAX Comparison Chart in %
View a ticker or compare two or three
VS
BIAWX vs. CGFAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIAWX is a StrongBuy and CGFAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CGFAX has more cash in the bank: 357B vs. BIAWX (4.35B). CGFAX pays higher dividends than BIAWX: CGFAX (0.23) vs BIAWX (0.00). BIAWX was incepted earlier than CGFAX: BIAWX (14 years) vs CGFAX (24 years). BIAWX (0.75) is less costly to investors than CGFAX (0.62). BIAWX (32.00) and CGFAX (32.00) have comparable annual turnover. BIAWX has a lower initial minimum investment than CGFAX: BIAWX (100) vs CGFAX (250). CGFAX annual gain was more profitable for investors over the last year : 4.20 vs. BIAWX (-16.43). CGFAX return over 5 years is better than : 15.81 vs. BIAWX (5.42).
BIAWXCGFAXBIAWX / CGFAX
Total Expense Ratio0.750.62121%
Annual Report Gross Expense Ratio0.750.62121%
Fund Existence14 years24 years-
Gain YTD5.9907.14984%
Front LoadN/A4%-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets4.35B357B1%
Annual Yield % from dividends0.000.23-
Returns for 1 year-16.434.20-391%
Returns for 3 years8.8638.9523%
Returns for 5 years5.4215.8134%
Returns for 10 years187.22106.94175%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONCY0.930.04
+4.69%
Oncolytics Biotech
RS385.406.18
+1.63%
Reliance
VINP9.79-0.22
-2.15%
Vinci Compass Investments Ltd
TTAM16.96-0.39
-2.25%
Titan America SA
ENVB1.31-0.05
-3.68%
Enveric Biosciences Inc.